Annual ROE
-791.49%
-716.44%-954.62%
December 31, 2023
Summary
- As of February 12, 2025, SMMT annual return on equity is -791.49%, with the most recent change of -716.44% (-954.62%) on December 31, 2023.
- During the last 3 years, SMMT annual ROE has fallen by -724.92% (-1088.96%).
- SMMT annual ROE is now -223.76% below its all-time high of 639.52%, reached on January 31, 2018.
Performance
SMMT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-104.22%
+51.12%+32.91%
September 30, 2024
Summary
- As of February 12, 2025, SMMT quarterly return on equity is -104.22%, with the most recent change of +51.12% (+32.91%) on September 30, 2024.
- Over the past year, SMMT quarterly ROE has increased by +51.12% (+32.91%).
- SMMT quarterly ROE is now -267.99% below its all-time high of 62.04%, reached on July 31, 2018.
Performance
SMMT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SMMT ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -954.6% | +32.9% |
| 3 y3 years | -1089.0% | -24.2% |
| 5 y5 years | -1968.9% | -75.6% |
SMMT ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -954.6% | at low | -24.2% | +81.8% |
| 5 y | 5-year | -1729.6% | at low | -94.4% | +81.8% |
| alltime | all time | -223.8% | at low | -268.0% | +99.4% |
Summit Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -104.22%(-32.9%) |
| Jun 2024 | - | -155.34%(+14.1%) |
| Mar 2024 | - | -136.15%(-76.2%) |
| Dec 2023 | -791.49%(+954.6%) | -571.82%(+14.6%) |
| Sep 2023 | - | -498.91%(+7.0%) |
| Jun 2023 | - | -466.06%(-13.6%) |
| Mar 2023 | - | -539.47%(+543.1%) |
| Dec 2022 | -75.05%(-31.1%) | -83.89%(-15.9%) |
| Sep 2022 | - | -99.70%(-1.1%) |
| Jun 2022 | - | -100.85%(-5.4%) |
| Mar 2022 | - | -106.62%(+8.0%) |
| Dec 2021 | -108.89%(+63.6%) | -98.70%(+5.9%) |
| Sep 2021 | - | -93.24%(-6.3%) |
| Jun 2021 | - | -99.55%(-12.1%) |
| Mar 2021 | - | -113.23%(+11.5%) |
| Dec 2020 | -66.57%(+53.9%) | - |
| Dec 2020 | - | -101.57%(-3.1%) |
| Sep 2020 | - | -104.87%(+75.7%) |
| Jun 2020 | - | -59.70%(+11.4%) |
| Mar 2020 | - | -53.61%(-9.7%) |
| Dec 2019 | -43.26%(-202.1%) | - |
| Oct 2019 | - | -59.35%(-0.9%) |
| Jul 2019 | - | -59.86%(-262.2%) |
| Apr 2019 | - | 36.90%(-10.3%) |
| Jan 2019 | 42.35%(-93.4%) | - |
| Jan 2019 | - | 41.16%(-5310.1%) |
| Oct 2018 | - | -0.79%(-101.3%) |
| Jul 2018 | - | 62.04%(-107.8%) |
| Apr 2018 | - | -794.46%(-62.3%) |
| Jan 2018 | 639.52% | - |
| Date | Annual | Quarterly |
|---|---|---|
| Jan 2018 | - | -2107.91%(+189.4%) |
| Oct 2017 | - | -728.37%(-66.5%) |
| Jul 2017 | - | -2177.14%(-87.6%) |
| Apr 2017 | - | -17.57 K%(+5233.4%) |
| Jan 2017 | -288.24%(+113.2%) | - |
| Jan 2017 | - | -329.51%(+66.9%) |
| Oct 2016 | - | -197.42%(+49.7%) |
| Jul 2016 | - | -131.88%(+42.4%) |
| Apr 2016 | - | -92.62%(+33.0%) |
| Jan 2016 | -135.18%(+7.9%) | - |
| Jan 2016 | - | -69.64%(+18.0%) |
| Oct 2015 | - | -59.02%(+13.2%) |
| Jul 2015 | - | -52.15%(-5.4%) |
| Apr 2015 | - | -55.13%(-15.1%) |
| Jan 2015 | -125.27%(-23.0%) | - |
| Jan 2015 | - | -64.96%(-15.0%) |
| Oct 2014 | - | -76.42%(-5.0%) |
| Jul 2014 | - | -80.41%(-43.1%) |
| Apr 2014 | - | -141.31%(+65.0%) |
| Jan 2014 | -162.65%(+0.9%) | - |
| Jan 2014 | - | -85.64%(+87.5%) |
| Oct 2013 | - | -45.68% |
| Jan 2013 | -161.17%(+82.8%) | - |
| Jan 2012 | -88.15%(+13.1%) | - |
| Jan 2011 | -77.94%(+15.0%) | - |
| Jan 2010 | -67.76%(-30.3%) | - |
| Jan 2009 | -97.25%(+127.5%) | - |
| Jan 2008 | -42.74%(+129.0%) | - |
| Jan 2007 | -18.66%(+145.5%) | - |
| Jan 2006 | -7.60%(+2203.0%) | - |
| Jan 2005 | -0.33% | - |
FAQ
- What is Summit Therapeutics annual return on equity?
- What is the all time high annual ROE for Summit Therapeutics?
- What is Summit Therapeutics annual ROE year-on-year change?
- What is Summit Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Summit Therapeutics?
- What is Summit Therapeutics quarterly ROE year-on-year change?
What is Summit Therapeutics annual return on equity?
The current annual ROE of SMMT is -791.49%
What is the all time high annual ROE for Summit Therapeutics?
Summit Therapeutics all-time high annual return on equity is 639.52%
What is Summit Therapeutics annual ROE year-on-year change?
Over the past year, SMMT annual return on equity has changed by -716.44% (-954.62%)
What is Summit Therapeutics quarterly return on equity?
The current quarterly ROE of SMMT is -104.22%
What is the all time high quarterly ROE for Summit Therapeutics?
Summit Therapeutics all-time high quarterly return on equity is 62.04%
What is Summit Therapeutics quarterly ROE year-on-year change?
Over the past year, SMMT quarterly return on equity has changed by +51.12% (+32.91%)